Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 1, 2003, Pages 148-159

  Uchiyama, Yuka ^a   Otani, Hajime ^a   Okada, Takayuki ^a   Uchiyama, Takamichi ^a   Ninomiya, Hideki ^a   Kido, Masakuni ^a   Imamura, Hiroji ^a   Nakao, Shinichi ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE; ADENOSINE TRIPHOSPHATE; CHELERYTHRINE; CREATINE KINASE; DIAZOXIDE; FLAVOPROTEIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; POTASSIUM; POTASSIUM CHANNEL; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE OXYGENATION; UPREGULATION;

EID: 0042844683     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00236-8     Document Type: Article

References (32)

1. Lu K, Otani H, Yamamura T, Nakao Y, et al. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia. J Thorac Cardiovasc Surg. 2001;121:137-48.
2. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res. 1996;79:627-30.
3. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res. 1998;40:9-22.
4. Gray MO, Karliner JS, Mochly-Rosen D. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-51.
5. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol. 1999;31:1937-48.
6. ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-6.
7. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88:802-9.
8. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation. 1991;84:350-6.
9. Lochner A, Marais E, Genade S, Moolman JA. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol. 2000;279:H2752-65.
10. Sato T, Sasaki N, O'Rourke B, Marban E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation. 2000;102:800-5.
11. Hattori R, Otani H, Uchiyama T, Imamura H, Cui J, Maulik N, et al. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2001;281:H1066-74.
12. Toombs CF, McGee S, Johnston WE, Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation. 1992;86:986-94.
13. Nakano A, Liu GS, Heusch G, Downey JM, Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 2000;32:1159-67.
14. Cave AC, Collis CS, Downey JM, Hearse DJ. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. Cardiovasc Res. 1993;27:663-8.
15. ATP channels. Am J Physiol. 1997;272:H334-42.
16. Belhomme D, Peynet J, Florens E, Tibourtine O, Kitakaze M, Menasche P. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg. 2000;70:590-4.
17. Toyoda Y, Di Gregorio V, Parker RA, Levitsky S, McCully JD. Anti-stunning and anti-infarct effects of adenosine-enhanced ischemic preconditioning. Circulation. 2000;102:III326-31.
18. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors. Am J Physiol Heart Circ Physiol. 2002;282:H1933-43.
19. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29:207-16.
20. 2+ levels. J Biol Chem. 2000;275:12223-30.
21. Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis of protein kinase Cε signaling complexes in the normal heart and during cardioprotection. Circ Res. 2001;88:59-62.
22. Ping P, Takano H, Zhang J, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
23. ATP channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J Mol Cell Cardiol. 2001;33:831-4.
24. Grover GJ, Garlid KD. ATP-sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol. 2000;32:677-95.
25. ATP channels. Am J Physiol Heart Circ Physiol. 2001;280:H2321-8.
26. Kolocassides KG, Galinanes M, Hearse DJ. Ischemic preconditioning, cardioplegia or both? J Mol Cell Cardiol. 1994;26:1411-4.
27. Schneider S, Chen W, Hou J, Steenbergen C, Murphy E. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning. Am J Physiol Heart Circ Physiol. 2001;280:H499-508.
28. Otani H, Kawasaki H, Ninomiya H, et al. Effects of ischemic preconditioning on the recovery of myocardial function after unprotected ischemia and cardioplegia in the isolated and crystalloid perfused rat hearts. Jpn J Thorac Cardiovasc Surg. 1997;45:23-30.
29. Ninomiya H, Otani H, Lu K, Uchiyama T, Kido M, Imamura H. Complementary role of extracellular ATP and adenosine in ischemic preconditioning in the rat heart. Am J Physiol Heart Circ Physiol. 2002;282:H1810-20.
30. Mentzer RM Jr, Birjiniuk V, Khuri S, et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg. 1999;229:643-9 (discussion 649-50).
31. ATP channel opening controls human myocardial preconditioning: too much of a good thing? Surgery. 2000;128:368-73.
32. Beckman JS. Parsing the effects of nitric oxide, S-nitrosothiols, and peroxynitrite on inducible nitric oxide synthase-dependent cardiac myocyte apoptosis. Circ Res. 1999;85:870-1.